Live feed
Filing
SC 13D/A
SC 13D/A0001193125-15-209050·LIGAND PHARMACEUTICALS INC
Schedule 13D ownership disclosure
Viking Therapeutics Inc
Security class unavailable · CUSIP: 92686J106
Event date: 2015-05-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 48.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-209050
- Form type
- SC 13D/A
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- Jun 01, 2015
- Reporting period
- May 28, 2015
- Description
- Schedule 13D beneficial ownership